Strategic Joint Venture in the United States - Senores Pharmaceuticals Ltd

Code BSE: 544319 NSE:

Senores Pharmaceuticals, Inc. announces Strategic Joint Venture in the United States, positioning the group for U.S. Federal and Defense Sector Supplies "Amerisyn is a major milestone for Senores. This will enable Senores to utilise its manufacturing and product expertise for supply to the U.S. government sector and unlock a high-entry-barrier market. We expect this partnership to be a significant driver of growth and a substantial contributor to our international business volumes moving forward." stated Swapnil Shah, Managing Director, Senores Pharmaceuticals Limited.